Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Peptides: Molecular and Biotechnological Aspects"
Deadline for manuscript submissions: 20 December 2019.
Interests: bioactive peptides; cancer; natural peptides; molecular biology; proteases and proteomic
According to the World Health Organization, thousands of deaths are related to an unhealthy diet that stands as one of the main risk factors for non-communicable diseases, also known as chronic diseases. Among these disorders, the most diffuse are cardiovascular diseases and cancers, which bear the major responsibility for mortality and morbidity. The increased incidence of these diseases leads to investigate new therapies. Peptides have been emerging as an alternative treatment for many disorders. They can interact with a specific target, eliciting a physiological effect. This specificity causes less side effects and lower toxicity and confers excellent safety, tolerability, and efficacy in humans.
On the other hand, these peptides have intrinsic weaknesses, with poor chemical and physical stability and short circulating plasma life. Many studies have been performed to design new drugs based on peptides, trying to minimize their disadvantages and improve their pharmacokinetic and pharmacodynamic characteristics. Despite numerous studies, the action mechanism of most peptides is not well known and necessitates further research.
The market of pharmaceutical peptides has been increasing proportionally to the number of researches, with a projected annual growth rate of 9–10%. In 2019, $70 billion of these medicines are expected to be sold, more than the amount predicted for pharmaceuticals worldwide.
Assoc. Prof. Hamilton Cabral
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- chronic diseases
- natural peptide
- mechanism of action
- peptide delivery
- peptide design
- peptide-protein interaction
- pharmaceutical peptide
- synthetic peptide
- biological activity of peptides
- peptide developments and peptide stability